Market Signal Briefing

Upgrade TJX Companies to buy, targeting a 10% 1-year return as fundamentals and growth drivers strengthen. TJX's consistent traffic-led comparable sales growth, especially among younger consumers, de-risks the brand and supports long-term relevance. HomeGoods' transformation into a year-round destination drives recurring traffic and smooths seasonal volatility, enhancing TJX's growth outlook.

LONDON & PARIS--(BUSINESS WIRE)--In a wide-scale licensing arrangement, ENGIE – a global energy player serving 20 million consumer contracts worldwide – has chosen Kaluza's Energy Intelligence Platform to deploy cutting-edge digital technologies aimed at enhancing customer experience and accelerating the shift to smarter, cleaner energy. Kaluza was selected by ENGIE for this multi-year, multi-market agreement following a rigorous evaluation of technology providers. Kaluza's platform combines re.

Highlights: Formation has commenced a fully funded 10,000 metre multi-phase drill program at its flagship N2 Gold Project near Matagami, Quebec, host to a global historic resource of ~870,000 ounces comprised of 18 Mt grading 1.5 g/t Au (~809,000 oz Au) across four zones (A, East, RJ-East, and Central)2,3 and 243 Kt grading 7.82 g/t Au (~61,000 oz Au) across the RJ zone2,4. Phase 1 will target the "A" zone, a shallow, highly continuous, low-variability historic gold deposit with ~522,900 ounces of which only ~35% of strike has been drilled (>3.1 km open), and the "RJ" zone, host to high-grade intercepts from historical drill holes as high as 51 g/t Au over 0.8 metres2, which was expanded by Agnico Eagle Mines in 2008 in the most recent drilling at the Property.

Roche Pharmaceuticals' CEO told investors she was "serious" about the goal of becoming a top 3 obesity player. The drugmaker's CT-388 weight loss injection is entering a phase III trial, marking the latest development in its nascent but fast-growing weight-loss portfolio.

The Invesco S&P 500 Momentum ETF is reiterated as a strong buy for its proven momentum-based strategy and consistent outperformance. SPMO's recent rebalancing increased technology exposure and reduced underperforming consumer defensive holdings, enhancing its sector allocation for current market conditions. SPMO delivered a 35.57% return over the past year, nearly doubling the S&P 500's 18.21%, showcasing its effectiveness in volatile markets.

SPDR® Portfolio S&P 500® High Dividend ETF is less performant than the S&P 500 and has dividends in line with Treasury yields. So why take the risk? Because simply it provides S&P 500 anchored exposure with competitive distributions, so it is a meeting point. Because simply it has a competitive distribution and a price supported by the underlying bullish nature of the S&P 500, even if here it has more value traits.

There is a small gap between Nippon Steel and the U.S. government over the authority of a golden share tied to its acquisition of U.S. Steel, the Japanese steelmaker's president said on Thursday.

This announcement contains inside information for the purposes of the retained UK version of the EU Market Abuse Regulation (EU) 596/2014 ("UK MAR").   Arecor Therapeutics plc (“Arecor” or the “Company”) Co-development Agreement with US Insulin Pump Device Company for AT278 and Sale of Royalty and Technology Access Fees for up to $11 million AT278 (500U/mL) is the only ultra-concentrated and ultra-rapid acting insulin in development designed to enable the next generation of longer-wear and miniaturised automated insulin delivery (AID) systems Arecor and Sequel Med Tech, LLC to commit up to $1.3 million each to fund development work in preparation for pivotal Phase 2 trial for AT278-Insulin Pump programme Strategic intent is to progress to a broader co-development and commercialisation partnership for Phase 2 trial and beyond Non-dilutive funds raised through the monetisation of Arecor's royalty rights related to AT220 and milestone and technology access fees related to AT292 Cash runway extended to 1H 2027 Cambridge, UK, 25 September 2025: Arecor Therapeutics plc (AIM: AREC), the biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases, has signed a co-development agreement with Sequel Med Tech LLC (“Sequel”), a company developing state-of-the-art insulin delivery technologies, to combine AT278 (500U/mL) with Sequel's twiist™ Automated Insulin Delivery (AID) system powered by Tidepool, and a royalty financing agreement with Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand”) which will raise non-dilutive capital of up to $11 million (£8.2 million).

Gold and silver steady as Fed rate cut bets clash with Powell's caution. PCE inflation data set to decide the next move for XAU/USD and XAG/USD.

Vaultz Capital PLC (AQSE:V3TC) has hired BitGo Trust Company to act as custodian for its Bitcoin holdings, the company said Thursday, in a move aimed at strengthening security and governance around its digital asset reserves. Vaultz, listed on London's Aquis Exchange, described the appointment as a key step in its treasury strategy as it builds out its digital asset operations.

India considers French engines for fighter jets amid slow US talks, aiming to boost domestic defence manufacturing capabilities.

The $100 billion partnership between Nvidia and OpenAI, announced Monday, represents – for now – the latest mega-deal reshaping the AI infrastructure landscape. The agreement involves non-voting shares tied to massive chip purchases and enough computing power for more than 5 million U.S. households, deepening the mutual dependence between two of AI's most powerful players.

WisdomTree U.S. High Dividend Fund offers high yields and value exposure, making it a strong supplement to core large-cap value ETFs. DHS provides a 3.26% yield, focuses on mature, cash-generative companies, but has high concentration risk in top holdings. Combining DHS with iShares Russell 1000 Value ETF enhances diversification, risk-adjusted returns, and sector balance for value investors.

BYD has overtaken Tesla in the European Union electric vehicle market for the second month running, shaking up what many assumed was an unchallenged race. In August 2025, BYD sold more than 13,500 vehicles across Europe, a staggering 200% increase year-over-year.

- Total non-dilutive funding of up to USD 159 million upon completion of predefined milestones, including near-term committed funding of USD 6 million

Rambus Inc. continues to deliver robust growth, driven by strong DDR5 memory interface chip sales and industry-leading market share. RMBS's diversified business model, resilience to tariffs, and leadership in DDR5, HBM4, and PCIe 7.0 position it for multi-year expansion. Despite a steep valuation after a 110% rally, RMBS's sustained earnings growth is expected to justify its premium over time.

Uranium Royalty Corp. (NASDAQ:UROY) rose to a three-year high after uranium futures in the US soared to a 10-month high of over $80 per pound this week. The price hike comes after U.S.

Liontown Resources Limited (OTCPK:LINRF) Q4 2025 Earnings Call September 24, 2025 9:30 PM EDT Company Participants Antonino Ottaviano - CEO, MD & Director Graeme Pettit - Interim Chief Financial Officer Ryan Hair - Chief Operating Officer Grant Donald - Chief Commercial Officer Conference Call Participants Glyn Lawcock - Barrenjoey Markets Pty Limited, Research Division Presentation Operator Welcome to the Liontown Resources FY '25 Results call. Following the formal presentation, there will be a Q&A session for investors, analysts and media.

Immuneering Announces Pricing of $175 Million Underwritten Public Offering of Class A Common Stock and Concurrent $25 Million Private Placement of Class A

Vancouver, British Columbia--(Newsfile Corp. - September 25, 2025) - District Metals Corp. (TSXV: DMX) (Nasdaq First North: DMXSE SDB) (OTCQB: DMXCF) (FSE: DFPP); ("District" or the "Company") is pleased to report its results for the year ended June 30, 2025. All amounts are in Canadian dollars, unless otherwise noted.

Vancouver, BC – TheNewswire - September 24, 2025 – KORE Mining Ltd. (TSXV: KORE) (“ KORE ” or the “ Company ”) is pleased to provide an update on its reinstatement to trading on the TSX Venture Exchange (the “ Exchange ”), and corporate updates. Reinstatement to Trading on the Exchange

Amplify CWP Growth and Income ETF offers a more tactical, flexible covered-call strategy compared to TappAlpha SPY Growth and Daily Income ETF. QDVO selects 20-40 large-cap stocks based on earnings and performance, selling options on individual holdings for enhanced total returns and income balance. TSPY provides higher, more consistent income by selling daily index calls, but its conservative approach limits upside compared to QDVO's nuanced strategy.

Investors need to pay close attention to Bandwidth stock based on the movements in the options market lately.

Roivant Sciences Ltd. (NASDAQ:ROIV ) Bank of America Global Healthcare Conference 2025 September 24, 2025 5:45 AM EDT Company Participants Matthew Gline - CEO & Director Conference Call Participants Jason Gerberry - BofA Securities, Research Division Presentation Jason Gerberry BofA Securities, Research Division We're at time.

Amazon remains the dominant force in e-commerce, leveraging its ecosystem, vertical integration, and global reach for sustained growth. AMZN's strategic business model, robust fundamentals, and effective cost management drive double-digit revenue growth and healthy margins, despite inflation and tariff challenges. Valuation is attractive, with AMZN trading below historical averages on key metrics, offering upside potential, with a target price range of $274-$315.